Ken Griffin’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Ken Griffin’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-83,839	Closed	-$17K	–	10167
2019 Q3	$17K	Buy	83,839 +43,284	+107%	+$29.3K	﹤0.01%	8981
2019 Q2	$35K	Buy	40,555 +24,480	+152%	+$38.3K	﹤0.01%	8836
2019 Q1	$37K	Sell	16,075 -1,471	-8%	-$3.99K	﹤0.01%	8937
2018 Q4	$40K	Buy	17,546 +4,079	+30%	+$36K	﹤0.01%	8544
2018 Q3	$200K	Buy	+13,467	New	+$214K	﹤0.01%	8216
2017 Q4	–	Sell	-19,793	Closed	-$440K	–	8691
2017 Q3	$440K	Buy	+19,793	New	+$434K	﹤0.01%	5505

Other funds holding SNNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Ken Griffin's SNNA Position: Q4 2019 in Review

Ken Griffin sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q4 2019, closing a stake of 83,839 shares — an estimated $17K sold.

Ken Griffin first reported a position in SNNA in Q3 2017 and held it in 6 quarters. The position peaked at $440K in Q3 2017. 4 funds tracked by Wall St. Rank hold SNNA as of Q4 2019.

Ken Griffin reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Ken Griffin sold 83,839 Sienna Biopharmaceuticals, Inc. shares in Q4 2019, an estimated $17K.
Ken Griffin first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 6 quarters.
Ken Griffin's Sienna Biopharmaceuticals, Inc. position peaked at $440K in Q3 2017.
4 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.